[ET Net News Agency, 4 July 2025] HANSOH PHARMA (03692) rose 3.1% to HK$31.35.
It hits an intra-day high of HK$31.5, hitting a 52-week high, and an intra-day low of
HK$29.95. The total shares traded was 2.83 million, with a value of HK$86.76m. The active
buy/sell ratio is 59:41, with net buying turnover of HK$14.18m. HSBC SEC BRO (ASIA)
accounts for greatest net responsive buying turnover of HK$7.19m, with volume weighted
average price of HK$30.597. MORGAN STANLEY HK SEC accounts for greatest net responsive
selling turnover of HK$5.6m, with volume weighted average price of HK$30.656. The stock
has risen a combined 8.2% over the past 4 consecutive trading days.
The Hang Seng Index now fell 164 points, or 0.7% to 23,905.

Basic Information
=================

---------------------------------
Nominal 31.350 % Chg +3.12%
High 31.500 Low 29.950
Shares Tr 2.83m Turnover 86.76m
10-D SMA 29.422 %H.V 32.637
20-D SMA 28.918 VWAP 30.654
50-D SMA 26.224 RSI14 75.169
---------------------------------
Status: Hitting a 52-week high, active buy/sell ratio is 59:41, with net buying turnover
of HK$14.18m, rising a combined 8.2% over the past 4 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 31.35 +3.12
CSPC PHARMA (01093) 8.21 -0.36
SINOPHARM (01099) 18.54 -0.11
SINO BIOPHARM (01177) 5.53 +1.47
INNOVENT BIO (01801) 86.00 +1.65
WUXI BIO (02269) 26.30 +1.94
WUXI APPTEC (02359) 80.50 +1.90
CHINARES PHARMA (03320) 5.21 -0.76
BEIGENE (06160) 148.10 -0.80
AKESO (09926) 115.30 +8.67
-----------------------------------------------
(ed)